InsiderTrades

Form 4 for WULF TERAWULF INC.

Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-30 · accession 0000950142-23-000254 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2023-02-01 2023-01-30 WULF Prager Paul B. CEO, Dir, 10% D - Sale to Iss — -12.00M 14.12M -46% —
DMI 2023-02-01 2023-01-30 WULF Prager Paul B. CEO, Dir, 10% A - Grant — +13.19M 12.00M New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common stock, $0.001 par value per share 2023-01-30 D D 12,000,000 — 14,124,121 I By Stammtisch Investments LLC — — (F1) Represents the surrender of 12,000,000 shares of common stock, $0.001 par value per share, of the Issuer ("Common Stock"), to the Issuer, in exchange for 12,000,000 warrants to purchase shares of Common Stock, at an exercise price of $0.00001 per share. (F2) By Stammtisch Investments LLC ("Stammtisch"). The Reporting Person is the sole manager of Stammtisch and, as a result, may be deemed to beneficially own the shares of the Common Stock held by Stammtisch. The Reporting Person disclaims beneficial ownership of such shares of the Common Stock except to the extent of his pecuniary interest therein, and the inclusion of such shares of the Common Stock in this report shall not be deemed an admission of beneficial ownership of all of the reported shares of the Common Stock for purposes of Section 16 of the Exchange Act, or for any other purpose.
2 Derivative Warrants to Purchase Common Stock 2023-01-30 A A 1,190,476 — 1,190,476 I By Allin WULF LLC — · — to 2023-12-31 1,250,000 Common Stock (F8) Represents the purchase from the Issuer of 1,190,476 warrants to purchase shares of Common Stock, at a price of $1.05 per Warrant for an aggregate purchase price of $1,250,000. The warrants are exercisable at a price of $0.00001 per share. (F3) By Allin WULF LLC ("Allin"). The Reporting Person is the sole manager of Allin and, as a result, may be deemed to beneficially own the shares of the Common Stock held by Allin. The Reporting Person disclaims beneficial ownership of such shares of the Common Stock except to the extent of his pecuniary interest therein, and the inclusion of such shares of the Common Stock in this report shall not be deemed an admission of beneficial ownership of all of the reported shares of the Common Stock for purposes of Section 16 of the Exchange Act, or for any other purpose. (F7) The warrants will be exercisable beginning on the first business day following the date on which the Issuer's shareholders approve an increase in the Issuer's authorized Common Stock. On February 1, 2023, the Issuer filed a preliminary proxy statement to hold a special meeting of its shareholders to amend the Issuer's charter to increase the maximum number of authorized shares of Common Stock from 200,000,000 to 400,000,000.
3 Derivative Warrants to Purchase Common Stock 2023-01-30 A A 12,000,000 — 12,000,000 I By Stammtisch Investments LLC — · — to 2023-12-31 12,000,000 Common Stock (F1) Represents the surrender of 12,000,000 shares of common stock, $0.001 par value per share, of the Issuer ("Common Stock"), to the Issuer, in exchange for 12,000,000 warrants to purchase shares of Common Stock, at an exercise price of $0.00001 per share. (F2) By Stammtisch Investments LLC ("Stammtisch"). The Reporting Person is the sole manager of Stammtisch and, as a result, may be deemed to beneficially own the shares of the Common Stock held by Stammtisch. The Reporting Person disclaims beneficial ownership of such shares of the Common Stock except to the extent of his pecuniary interest therein, and the inclusion of such shares of the Common Stock in this report shall not be deemed an admission of beneficial ownership of all of the reported shares of the Common Stock for purposes of Section 16 of the Exchange Act, or for any other purpose. (F7) The warrants will be exercisable beginning on the first business day following the date on which the Issuer's shareholders approve an increase in the Issuer's authorized Common Stock. On February 1, 2023, the Issuer filed a preliminary proxy statement to hold a special meeting of its shareholders to amend the Issuer's charter to increase the maximum number of authorized shares of Common Stock from 200,000,000 to 400,000,000.